Cannabis for Cancer

While nearly 1 in 4 patients with cancer report using cannabis and over two-thirds of states in the U.S. have legalized medical cannabis in some form, more comprehensive and clinically useful data on how cannabis use affects patient outcomes is seriously lacking. Research has found strong evidence of racial disparities in pain outcomes among cancer patients and differences in cannabis use risk perception by race/ethnicity. However, little is known about the role of cannabis in addressing racial disparities in pain outcomes for Black/African American patients with cancer.

The purpose of this observational study is to ultimately inform oncology clinical practice, cancer pain guidelines, and perhaps public policy to generate a significant public health impact benefitting millions of cancer patients who live with moderate to severe pain, plus thousands of clinicians who manage cancer pain to integrate evidence-informed cannabis guidelines into practice.

This study is being conducted at the University at Buffalo in collaboration with Thomas Jefferson University, the University of Pennsylvania, and Roswell Park Cancer Institute.

Selected Publications

Least Pain Scores

Characterizing anxiety, pain, sleep and QOL


We are seeking Cannabis and Non-Cannabis Users Who…

  • Have received treatment for their cancer within the past 3 years
  • Identify as Black/African American or White/Caucasian
  • Have a prescription for opioids to manage pain

If you relate to any of the above, you may be eligible for this study!

Give us a call at 716-829-2024 to find out today!